Occupational Therapists in Port Washington, NY Accepting Medicare

9 Occupational Therapists found. Showing 1 - 9

Bridget Kavanagh, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 E Overlook, Port Washington, NY 11050 Phone: 631-617-3218

Mrs. Donna Lee Kosina, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Maple Dr., Port Washington, NY 11050 Phone: 516-570-0193

Mrs. Jamie Lynn Mandel, M.A. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 61 Highland Ave, Port Washington, NY 11050 Phone: 516-883-3560

Kathleen Warford Jay, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12 Monroe St, Port Washington, NY 11050 Phone: 516-944-7468

Cassandra Newby Occupational Therapist Medicare: Medicare Enrolled Practice Location: 300 E Overlook, Port Washington, NY 11050 Phone: 516-472-6610

Mrs. Marna K Keane, OTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 Dock Ln, Port Washington, NY 11050 Phone: 516-767-9518

Gail Grubman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 85a Bayview Ave, Port Washington, NY 11050 Phone: 516-767-6979

Jennifer Hallissy, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 24 Nesaquake Ave, Port Washington, NY 11050 Phone: 516-767-3879

Judi Sobel Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 36 Amherst Rd, Port Washington, NY 11050 Phone: 516-767-1360

News Archive

Research sheds light on why cervical precancers disappear in some women and not in others

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists say the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.

Taro Pharmaceutical Industries initiates its T2007 non-sedating barbiturate compound Phase I clinical trials

Taro Pharmaceutical Industries Ltd. announced that it has begun Phase I clinical trials in Canada with T2007, the second in the Company's class of proprietary non-sedating barbiturate compounds to be approved for studies in humans.

New equation to calculate energy requirement for underweight COPD patients

Malnutrition often goes hand in hand with COPD and is difficult to treat. In a recent study researchers at the University of Gothenburg, have come up with a new equation to calculate the energy requirement for underweight COPD patients. It is hoped that this will lead to better treatment results and, ultimately, better quality of life for these patients.

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

Doctor in Israel reinfected with COVID-19 three months after recovering

There is still a lot to learn about coronavirus disease (COVID-19), which is currently ravaging across the globe. Though scientists are slowly gaining a better understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is still unclear if being infected once may provide long-lasting immunity against the novel coronavirus.

Read more Medical News

› Verified 9 days ago